ICLR - ICON in pact with BARDA for next-gen COVID vaccine trial
2023-09-13 08:52:47 ET
More on Icon
- Seeking Alpha’s Quant Rating on Icon
- Historical earnings data for Icon
- Financial information for Icon
- ICON: Economic Business Returns Lagging Capital Charge, Revise To Hold
- ICON Public Limited Company ( ICLR ) Q2 2023 Earnings Call Transcript
- Regeneron, J&J receive millions to develop new COVID therapies
- Icon Non-GAAP EPS of $3.11 beats by $0.03, revenue of $2.02B in-line
- What’s next for clinical research firms after pandemic boom?
For further details see:
ICON in pact with BARDA for next-gen COVID vaccine trial